PHI with Fibroadenoma surgery
How does this condition affect your private health insurance?
Fibroadenomoperation refers to the surgical excision of a fibroadenoma, a common, benign, solid breast lump typically found in women under 30. These non-cancerous tumors are composed of glandular and stromal tissue, often feeling firm, smooth, and movable. While many fibroadenomas are monitored, surgery is performed if they grow large, cause discomfort, or if there's diagnostic uncertainty. The procedure, usually an excisional biopsy or lumpectomy, removes the mass, providing definitive diagnosis and alleviating symptoms. Recovery is generally straightforward, though scarring is typical. It's a highly effective treatment for this benign condition.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Variable, from several months to years before diagnosis and removal.
Duration of Illness (Lifetime)
Typically a one-time event for a specific fibroadenoma; however, new fibroadenomas can develop over a lifetime.
Cost of Treatment (Initial)
Ranges from $3,000 to $10,000, including surgeon's fees, anesthesia, facility costs, and pathology.
Cost of Treatment (Lifetime)
Primarily the cost of the initial surgery, plus potential costs for follow-up imaging or if new fibroadenomas require removal.
Mortality Rate
Extremely low (negligible) associated with the surgical procedure itself.
Risk of Secondary Damages
Low; potential for scarring, temporary pain, infection (1-5%), hematoma, seroma, minor breast asymmetry. Psychological impact from breast surgery can occur.
Probability of Full Recovery
Very high (over 95%) with complete removal of the benign fibroadenoma and no significant complications.
Underlying Disease Risk
Very low; fibroadenomas are generally isolated benign findings. They do not typically indicate other severe underlying diseases, though regular breast cancer screening is always recommended.